Maintenance venom immunotherapy administered at a 3-month interval preserves safety and efficacy and improves adherence.

Abstract

The study confirms that the conventional MVIT interval of 4 to 6 weeks can be extended to 3 months in most patients with no adverse events, while maintaining safety and efficacy, improving adherence, and guaranteeing safe continuation of professional activity.